PGNX Progenics Pharmaceuticals Inc.

$7.515 -10.11%

4,752,029 Shares Traded
1,500,808 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $6.57 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-35.93%
If Intiated One Month Ago, Shorts Have Realized a Return of:-39.57%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.95%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 10.94%
Short Interest7.77 million
Float71 million
Short Ratio6.01
Market Cap$607.45 million
Market Maker ActivityDaily Short Volume


Premarket Losers as of 9:05 am (3/23/2018) (SeekingAlpha)
After Hours Gainers / Losers (3/22/2018) (SeekingAlpha)
FDA extends action date three months for Progenics' Azedra (SeekingAlpha)
3 Things In Biotech, March 19: Progenics, Denali, Regeneron. Gains All Around (SeekingAlpha)
The No BS Plan Report, Week 5: Does Sideways Movement Mean An Imminent Inflection Point? (SeekingAlpha)
Progenics: This Is Just The Beginning (SeekingAlpha)
The Speculative-Team: March 2018 Review (SeekingAlpha)
Our Post-Earnings Take On Progenics Pharmaceuticals (SeekingAlpha)
The No BS Plan, Week 4: Whoa! (SeekingAlpha)
Your Daily Pharma Scoop: Progenics Rallies, Merck To Partner With Eisai, Teva Upsizes Debt Offering (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 75%
Insider Percent2.4%

Earnings Stats

PE Ratio -8.38
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $6.39
50 Day Moving Average $6.62
52 Week High $11.48
52 Week Low $4.6

Data provided for free by IEX. Questions? Read the FAQ